FDA
approval
· 2024-07-26
FDA Approved: VENXXIVA — Supplemental Application (Cycle Pharmaceuticals Ltd.)
Summary
The FDA approved a supplemental application for VENXXIVA (tiopronin) submitted by Cycle Pharmaceuticals Ltd. under ANDA216990. The action authorizes the changes…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for VENXXIVA (TIOPRONIN)